YARM MEDICAL PRACTICE — All Prescriptions & Medications — Page 10
Practice Code: A81027 | YARM, TS15 9DD
Showing results 451-500 of 653
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| 32 | 2,060 | £3.9K | +97.5% ▲ | |
| Methyldopa | 31 | 2,800 | £1.3K | +82.0% ▲ |
| Erythromycin ethylsuccinate | 31 | 4,500 | £472 | +32.8% ▲ |
| Glucagon | 31 | 43 | £619 | +103.8% ▲ |
| Vardenafil | 31 | 248 | £467 | +122.0% ▲ |
| Mefenamic acid | 31 | 1,214 | £244 | -31.4% ▼ |
| Naloxegol | 30 | 210 | £370 | +117.5% ▲ |
| Sotalol hydrochloride | 30 | 2,688 | £83 | -57.3% ▼ |
| Cyclizine lactate | 30 | 266 | £264 | +100.0% ▲ |
| Domperidone | 30 | 6,313 | £1.3K | -15.9% ▼ |
| Degarelix | 30 | 30 | £3.3K | +72.9% ▲ |
| Lodoxamide trometamol | 30 | 300 | £149 | +391.7% ▲ |
| Chlorhexidine gluconate | 30 | 12.8K | £271 | +1.6% vs avg |
| Other toiletry preparations | 30 | 11.7K | £314 | -29.8% ▼ |
| 30 | 5,300 | £1.1K | +2.1% ▲ | |
| Tinzaparin sodium | 29 | 719 | £4.8K | +95.8% ▲ |
| Prasugrel | 29 | 868 | £383 | -7.7% ▼ |
| Desloratadine | 29 | 1,310 | £113 | +0.5% vs avg |
| Buspirone hydrochloride | 29 | 4,830 | £607 | -42.4% ▼ |
| Brivaracetam | 29 | 2,600 | £3.7K | -14.7% ▼ |
| Combined ethinylestradiol 35mcg | 29 | 2,366 | £162 | +132.8% ▲ |
| Brinzolamide/brimonidine | 29 | 245 | £430 | -15.5% ▼ |
| 29 | 476 | £156 | +143.3% ▲ | |
| Liquid OTC glucose for diabetic hypo treatment (0913541) | 28 | 19.8K | £307 | +22.2% ▲ |
| Benzoyl peroxide | 28 | 1,200 | £207 | +98.7% ▲ |
| Other individually formulated bought in preparations | 28 | 998 | £316 | -14.3% ▼ |
| 28 | 222 | £230 | +155.7% ▲ | |
| 28 | 2,190 | £1.1K | +124.3% ▲ | |
| Indometacin | 27 | 3,051 | £207 | +71.6% ▲ |
| Leflunomide | 27 | 1,050 | £63 | -28.7% ▼ |
| Budesonide | 27 | 51 | £545 | +73.6% ▲ |
| 27 | 292 | £339 | -16.6% ▼ | |
| 27 | 2,575 | £105 | +59.8% ▲ | |
| 27 | 1,030 | £1.8K | +65.4% ▲ | |
| Powder 1.6 kcal/ml milkshake (0913011) | 26 | 1,307 | £672 | -65.1% ▼ |
| Sodium chloride | 26 | 800 | £420 | -12.6% ▼ |
| 26 | 214 | £535 | +498.7% ▲ | |
| 26 | 2,100 | £5.1K | +47.5% ▲ | |
| Codeine phosphate | 25 | 7,000 | £81 | +74.2% ▲ |
| Clonidine hydrochloride | 25 | 5,020 | £483 | -53.1% ▼ |
| Quinine bisulfate | 25 | 916 | £166 | -35.6% ▼ |
| Estradiol valerate | 25 | 2,436 | £203 | +28.0% ▲ |
| 25 | 323 | £242 | +23.6% ▲ | |
| Sucralfate | 24 | 11.2K | £12.9K | +185.8% ▲ |
| Linaclotide | 24 | 700 | £892 | +31.4% ▲ |
| Olmesartan medoxomil | 24 | 896 | £59 | -65.2% ▼ |
| Bempedoic acid/Ezetimibe | 24 | 952 | £1.8K | -60.7% ▼ |
| Celecoxib | 24 | 1,746 | £76 | -63.7% ▼ |
| Terbinafine hydrochloride | 24 | 750 | £135 | -35.3% ▼ |
| 24 | 240 | £487 | -5.5% ▼ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.